Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Imaging Studies VII: Vascular Imaging01:19

Imaging Studies VII: Vascular Imaging

DefinitionRenal angiography, also known as renal arteriography, is an imaging technique used to obtain a comprehensive view of blood flow and the vascular structure of blood vessels in the kidneys and surrounding areas.PurposeRenal angiography detects blood vessel abnormalities in the kidneys, such as aneurysms, stenosis, thrombosis, vascular tumors, and renal artery stenosis. It evaluates kidney function and guides interventional treatments like angioplasty or stent placement.Pre-Procedure...
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Methods for Defining Equity-Stratifying Variables: A Systematic Review of Validation Studies.

Journal of clinical epidemiology·2026
Same author

The landscape of serum autoantibodies in lupus nephritis.

Autoimmunity reviews·2026
Same author

Comparing Catheters to Fistulas in Older Patients Starting Hemodialysis (ACCESS HD).

Journal of the American Society of Nephrology : JASN·2026
Same author

Identification of Maintenance Dialysis Recipients in Administrative Health Data: A Systematic Review.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2026
Same author

Patient and Healthcare Provider Priorities for Risk Prediction of Hospital Readmission: A Nominal Group Technique Consensus Study.

Journal of general internal medicine·2026
Same author

Identification of Maintenance Dialysis Recipients From an Electronic Clinical Information System and Effects on Estimates of Incidence and Prevalence.

Kidney medicine·2026

関連する実験動画

Updated: Jun 14, 2026

Intravascular Delivery of Biologics to the Rat Kidney
07:29

Intravascular Delivery of Biologics to the Rat Kidney

Published on: September 1, 2016

アテロエンボリック腎臓病は,腎臓の

Francesco Scolari1, Pietro Ravani

  • 1Faculty of Medicine, University of Brescia, Brescia, Italy. fscolar@tin.it

Lancet (London, England)
|April 13, 2010
PubMed
まとめ

腎臓動脈をブロックするコレステロール結晶によって引き起こされるアテロエンボリック腎疾患は,予後が悪い. スタチンを含む予防と症状的治療が鍵であり,ステロイドは重症症例を助ける可能性がある.

科学分野:

  • ネフロロジーは腎臓科です.
  • 心血管医学 心血管医学
  • 病理学 パトロジー

背景:

  • アテロエンボリック腎疾患は,アテロマトス性プラークの破裂とコレステロール結晶の腎動脈への栓塞によるものです.
  • 栓塞は皮膚,胃腸,脳を含む複数の臓器に影響を与え,診断を複雑にする.
  • この状態は,血管の処置や抗凝固剤の投与後にしばしば発生しますが,自発的な症例も発生します.

研究 の 目的:

  • アテロエンボリック腎疾患の病理生理学,診断,予後,および管理を要約する.
  • 診断上の課題と主要な臨床的特徴を強調する.
  • 現在のおよび潜在的な治療戦略の概要を述べる.

主な方法:

  • アテロエンボリック腎疾患に関する既存の文献のレビュー.
  • 診断基準の分析,臨床プレゼンテーションと支持的な発見を含む.
  • 治療方法と予後要因の評価.

主要な成果:

  • クラシックな診断トライアッドには,原因となる事象,急性/次急性腎不全,皮膚病変が含まれています.
  • 網膜の循環中のエオシノフィリアとコレステロールの結晶は,診断を支持し,しばしば生検によって確認されます.

さらに関連する動画

Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients
05:31

Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients

Published on: September 20, 2020

関連する実験動画

Last Updated: Jun 14, 2026

Intravascular Delivery of Biologics to the Rat Kidney
07:29

Intravascular Delivery of Biologics to the Rat Kidney

Published on: September 1, 2016

Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients
05:31

Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients

Published on: September 20, 2020

  • 腎機能と患者の生存率の両方の予後は,一般的に貧弱です.
  • 結論:

    • 早期に原因を認識し回避することは,予防に極めて重要です.
    • 高血圧,心臓,腎不全の症状的な管理は不可欠です.
    • スタチンはプラークの安定化のために推奨され,ステロイドは炎症的なケースに利益をもたらす可能性があります.